<DOC>
	<DOCNO>NCT02608970</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability , pharmacokinetics BMS-986177 healthy subject</brief_summary>
	<brief_title>Safety Tolerability Study BMS-986177 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Healthy subject determine clinically significant deviation normal medical history , physical examination , ECGs clinical laboratory determination Body Mass Index ( BMI ) 18 30 kg/m2 inclusive . BMI = weight ( kg ) / [ height ( ) ] 2 Females childbearing potential ( i.e. , postmenopausal surgically sterile ) men age 18 55 , inclusive Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG clinical laboratory determination beyond consistent target population Any condition could affect drug absorption Other protocoldefined exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>